Perbak Capital Partners’s NOV NOV Stock Holding History

Perbak Capital Partners’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-24,118	Closed	-$367K	–	317
2025 Q1	$367K	Buy	+24,118	New	+$361K	0.27%	51

Other funds holding NOV

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Perbak Capital Partners's NOV Position: Q2 2025 in Review

Perbak Capital Partners sold out of NOV (NOV) in Q2 2025, closing a stake of 24,118 shares — an estimated $367K sold.

Perbak Capital Partners first reported a position in NOV in Q1 2025 and held it in 1 quarter. The position peaked at $367K in Q1 2025. 431 funds tracked by Wall St. Rank hold NOV as of Q2 2025.

Perbak Capital Partners reported no remaining NOV position as of Q2 2025 after selling out during the quarter.
Perbak Capital Partners sold 24,118 NOV shares in Q2 2025, an estimated $367K.
Perbak Capital Partners first reported a position in NOV in Q1 2025 and held it in 1 quarter.
Perbak Capital Partners's NOV position peaked at $367K in Q1 2025.
431 funds tracked by Wall St. Rank held NOV as of Q2 2025.

Based on Perbak Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.